# Progress Note 03 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Jean-Jacques Rousseau (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN003-SYN-TD
- Date: 1767-03-10
- Fictional facility: St. Posthumous Health Center
- Fictional author: Celestine Marchetti-Owusu, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Seven-week review of psychotherapy and safety; preparation for urethroplasty. **S**

## History of present illness

Mr. Rousseau returns five weeks after the psychiatry consultation. He has had three sessions of cognitive behavioral therapy for psychosis and says the psychologist listens to him without calling him mad. He keeps a sleep diary and now rises at the same time each day; he sleeps about four and a half to five hours. He still holds the same beliefs about his former friends but has agreed with the psychologist to test one fear each week, and he has opened two letters he had set aside, which contained nothing he feared. He again declined aripiprazole today, saying he would rather see what the therapy does first. He met the urology surgeon three weeks ago, read the information on each option, and has chosen urethroplasty, which is booked in two weeks. He has used no sounds for seven weeks; his stream is thin but he has not been unable to pass urine. He has had no thoughts of suicide or of harming anyone. **S**

| Element | Detail |
|---|---|
| Psychotherapy | Three CBT sessions; weekly behavioral tests of one fear |
| Sleep | Four and a half to five hours; fixed rising time |
| Medication decision | Aripiprazole declined again; offer remains open |
| Urology decision | Chose excision and primary anastomosis urethroplasty, booked in two weeks |
| Urethral rest | No sounds for seven weeks; no retention |
| Safety | No thoughts of suicide or of harming anyone |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Genitourinary | Positive | Thin stream and straining; no retention, fever, or blood |
| Constitutional | Negative | Weight stable; no fever |
| Cardiovascular | Negative | No chest pain or breathlessness on long walks |
| Psychiatric | Positive | Persecutory beliefs unchanged; less time spent on them; no hallucinations; no thoughts of suicide or of harming anyone |

4 systems reviewed. **S**

## Current medications

- No current medications. **S**

## Allergies

- No known allergy **S**

## Objective

BP 126/80 mmHg; pulse 78 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 64 kg; BMI 23.2 kg/m². All vital signs are synthetic.

PHQ-9: 7; IPSS symptom score: 22; Post-void residual (bladder scan): 210 mL (high); Urine white cells: 2 /[HPF]; Creatinine: 1.04 mg/dL; eGFR: 85 mL/min/1.73 m²; Potassium: 4.3 mmol/L; Hemoglobin: 14.4 g/dL. All results are synthetic.

## Change since baseline

- PHQ-9: 8 at baseline, 7 at this visit **S**
- IPSS symptom score: 24 at baseline, 22 at this visit **S**
- Post-void residual (bladder scan): 180 mL (high) at baseline, 210 mL (high) at this visit **S**
- Urine white cells: 3 /[HPF] at baseline, 2 /[HPF] at this visit **S**
- Creatinine: 1.02 mg/dL at baseline, 1.04 mg/dL at this visit **S**
- eGFR: 87 mL/min/1.73 m² at baseline, 85 mL/min/1.73 m² at this visit **S**
- Potassium: 4.4 mmol/L at baseline, 4.3 mmol/L at this visit **S**
- Hemoglobin: 14.6 g/dL at baseline, 14.4 g/dL at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; walked to the clinic |
| Mental status | Calm and courteous; mood "a little steadier"; affect less anxious; persecutory beliefs unchanged in content, held with slightly less certainty; no hallucinations; no suicidal or violent ideation; understands, weighs, and can explain back the benefits and risks of the operation |
| Cardiovascular | Regular rhythm; no murmur |
| Abdomen | Bladder not palpable; right inguinal hernia small and reducible |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Delusional disorder, persecutory type** (F22). Engaged in CBT for psychosis, with less distress and a little more flexibility about one belief; sleep still short. PHQ-9 7. He has again made an informed choice not to take an antipsychotic now, which is respected. Risk remains low. He has the capacity to consent to the operation: he understands the options, appreciates how they apply to him, weighs them, and states a consistent choice, and his beliefs do not concern the surgical team. **S**
   - Continue CBT for psychosis.
   - Aripiprazole remains available whenever he wants to try it.
   - Safety plan reviewed and unchanged; the 988 Suicide & Crisis Lifeline confirmed.
   - Monthly PHQ-9 to be done at his CBT sessions, after the February check was missed.
2. **Bulbar urethral stricture before urethroplasty** (N35.812). Seven weeks of urethral rest without retention; residual 210 mL. Creatinine 1.04 mg/dL and hemoglobin 14.4 g/dL; urinalysis without infection, and the urology team's urine culture showed no growth, so he is fit for surgery. **S**
   - Excision and primary anastomosis bulbar urethroplasty in two weeks, his choice; consent signed with the urology team.
   - Catheter for about three weeks, with a urethrogram around the catheter before it is removed.
   - Acetaminophen for pain afterwards rather than opioids, which can cause constipation and retention.
   - Continue urethral rest; come in the same day if he cannot pass urine.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Suicide and violence risk review (C-SSRS Since Last Visit, PHQ-9 item 9, thoughts of harming others, plans to confront anyone, access to weapons) and the safety plan | Every visit | Completed today | No thoughts of suicide or of harming anyone; no plan to confront anyone; no weapons; PHQ-9 item 9 scored 0; safety plan reviewed |
| Survey | PHQ-9 for depressive symptoms | Baseline, then at least monthly while symptoms are being treated | Completed today | 7, down from 8 |
| Survey | Monthly PHQ-9 between the first visit and today | At least monthly | Deferred | Missed: the check due in mid-February was not done because there was no visit between the second visit and today. Today's score is lower, and no worsening of mood was reported to the psychologist, so no harm is judged to have resulted. Corrective action: the psychologist will give the PHQ-9 at each CBT session |
| Referral | Cognitive behavioral therapy for psychosis | About 16 sessions | Completed today | Three sessions so far; engaged |
| Medication safety | Antipsychotic offered again | When declined, offered again at later visits | Completed today | Declined again; his reasons recorded; offer kept open |
| Laboratory | Metabolic baseline and AIMS before an antipsychotic | Before starting | Not indicated | No antipsychotic started |
| Survey | IPSS | At diagnosis, before surgery, and after treatment | Completed today | 22, severe |
| Imaging | Post-void residual during urethral rest | Before surgery and with any change in voiding | Completed today | 210 mL; no retention |
| Laboratory | Creatinine, eGFR, potassium, hemoglobin, and urinalysis before surgery | Before urethroplasty | Completed today | Creatinine 1.04 mg/dL, eGFR 85, potassium 4.3 mmol/L, hemoglobin 14.4 g/dL, urine white cells 2 per high-power field |
| Examination | Capacity to consent to surgery | Before an operation when capacity could be questioned | Completed today | Capacity present for the urethroplasty decision |
| Self-management | Urethral rest | From diagnosis until surgery | Completed today | No sounds for seven weeks |
| Examination | Inguinal hernia check | At each review while under watchful waiting | Completed today | Small and reducible; not to be repaired at the urethroplasty |

## Goal progress

- Sleep at least six hours most nights. In progress; target 1767-07-14. **S**
- Less distress and preoccupation from the beliefs, so that he can write each morning and walk without fear. In progress; target 1767-07-14. **S**
- Stay in care: keep visits and psychotherapy sessions, with no sudden break in treatment. In progress; target 1767-12-15. **S**
- Pass urine with a free stream without self-dilation: maximum flow above 15 mL/s and post-void residual below 100 mL within three months of surgery. In progress; target 1767-07-14. **S**
- No harm to himself or anyone else; safety plan kept current. In progress; target 1767-12-15. **S**

## Guideline basis

- The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition. Am J Psychiatry 2020;177(9):868-872 (2020), American Psychiatric Association
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (PHQ-9, suicide-risk review, and second-generation antipsychotic monitoring) (2026), Aether Forge
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- Urethral Stricture Disease: AUA Guideline Amendment (2023). Wessells H, et al. J Urol 2023;210(1):64-71. PMID 37096574 (2023), American Urological Association
- International guidelines for groin hernia management. HerniaSurge Group. Hernia 2018;22(1):1-165 (2018), HerniaSurge Group (European Hernia Society and partner societies)

## Follow-up

- Urethroplasty in two weeks; catheter removal at about three weeks with a urethrogram; primary care review one week after the catheter comes out. **S**
- Next scheduled visit 1767-04-21: review four weeks after urethroplasty; start of aripiprazole. **S**
